A point prevalence cross-sectional study of healthcare-associated urinary tract infections in six Australian hospitals

BMJ Open

Volumn 4, Issue 7, 2014, Pages

  Gardner, Anne ^a   Mitchell, Brett ^a,b   Beckingham, Wendy ^c   Fasugba, Oyebola ^a  

^a AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^b AVONDALE COLLEGE OF HIGHER EDUCATION   (Australia)

^c CANBERRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANDIDA; CASE MIX; CATHETER INFECTION; CROSS-SECTIONAL STUDY; DIAGNOSIS RELATED GROUP; DISEASE SURVEILLANCE; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; FOLLOW UP; HEALTH SURVEY; HEALTHCARE ASSOCIATED INFECTION; HUMAN; ICD-10; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PREVALENCE; PROTEUS; PSEUDOMONAS; STAPHYLOCOCCUS AUREUS; URINARY CATHETER; URINARY TRACT INFECTION; URINE RETENTION; URINE VOLUME; AUSTRALIA; BACTERIAL INFECTIONS; CATHETER-RELATED INFECTIONS; CROSS INFECTION; MIDDLE AGED; URINARY TRACT INFECTIONS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; BACTERIAL INFECTIONS; CATHETER-RELATED INFECTIONS; CROSS INFECTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; URINARY TRACT INFECTIONS;

EID: 84905035817     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-005099     Document Type: Article

References (45)

1. Umscheid C, Mitchell M, Doshi J, et al. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 2011;32:101-14.
2. Allegranzi B, Nejad SB, Combescure C, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 2011;377:228-41.
3. Klompas M, Yokoe D. Automated surveillance of healthcare-associated infections. Clin Infect Dis 2009;48:1268-75.
4. European Centre for Disease Prevention and Control (ECDC). Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2011-2012. Stockholm: ECDC, 2013.
5. Kohn LT, Corrigan JM, Donaldson MS. To err is human: building a safer health system. Washington, DC: National Academy Press, 1999.
6. National Health and Medical Research Council. Australian Guidelines for the Prevention and Control of Infection in Healthcare 2010. http://www.nhmrc. gov.au/-files-nhmrc/publications/attachments/cd33-complete.pdf (accessed 25 Jul 2013).
7. Gravel D, Taylor G, Ofner M, et al. Point prevalence survey for healthcare-associated infections within Canadian adult acute-care hospitals. J Hosp Infect 2007;66:243-8.
8. Smyth ETM, McIlvenny G, Enstone JE, et al. Four Country Healthcare Associated Infection Prevalence Survey 2006: overview of the results. J Hosp Infect 2008;69:230-48.
9. Gould CV, Umscheid CA, Agarwal RK, et al. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol 2010;31:319-26.
10. Elvy J, Colville A. Catheter associated urinary tract infection: what is it, what causes it and how can we prevent it? J Infect Prev 2009;10:36-41.
11. Jain P, Parada JP, David A, et al. Overuse of the indwelling urinary tract catheter in hospitalized medical patients. Arch Intern Med 1995;155:1425-9.
12. Munasinghe R, Yazdani H, Siddique M, et al. Appropriateness of use of indwelling urinary catheters in patients admitted to the medical service. Infect Control Hosp Epidemiol 2001;22:647-9. (Pubitemid 33152109)
13. Saint S, Wiese J, Amory JK, et al. Are physicians aware of which of their patients have indwelling urinary catheters? Am J Med 2000;109:476-80.
14. Warren JW. Catheter-associated urinary tract infections. Int J Antimicrob Agents 2001;17:299-303. (Pubitemid 32288748)
15. Umscheid C, Mitchell M, Agarwal R, et al. Mortality from reasonably-preventable hospital acquired infections. Included in written testimony by the Society of Healthcare Epidemiology of America for the Committee on Oversight and Government Reform Hearing on Healthcare-associated Infections: A Preventable Epidemic, chaired by Henry A. Waxman, April 16, 2008 (Congressional Testimony). Washington, DC 2008.
16. McLaws ML, Gold J, King K, et al. The prevalence of nosocomial and community-acquired infections in Australian hospitals. Med J Aust 1988;149:582-90. (Pubitemid 19023422)
17. Graves N, Tong E, Morton AP, et al. Factors associated with health care-acquired urinary tract infection. Am J Infect Control 2007;35:387-92. (Pubitemid 47095067)
18. Reed CS, Gorrie G, Spelman D. Hospital infection control in Australia. J Hosp Infect 2003;54:267-71. (Pubitemid 37554921)
19. Cruickshank M, Ferguson J, Bull A. Reducing harm to patients from health care associated infection: the role of surveillance. Chapter 3: surgical site infection - an abridged version. Healthcare Infect 2009;14:109-14.
20. McLaws M, Taylor P. The hospital infection standardised surveillance (HISS) programme: analysis of a two-year pilot. J Hosp Infect 2003;53:259-67. (Pubitemid 38002037)
21. Richards M, Russo P. Surveillance of hospital-acquired infections in Australia - one nation, many states. J Hosp Infect 2007;65:174-81. (Pubitemid 46805860)
22. Health Protection Agency. Fourth National Point Prevalence Survey on Healthcare Associated Infections and First National Point Prevalence Survey on Antimicrobial Use and Quality Indicators in England 2011. http://www.hpa.org.uk/ webc/HPAwebFile/HPAweb-C/1296687778967 (accessed 25 Jul 2013).
23. Centres for Disease Control and Prevention. NHSN Patient Safety Component Manual 2012. http://www.cdc.gov/nhsn/pdfs/pscManual/7pscCAUTIcurrent.pdf (accessed 25 Jul 2013).
24. Centers for Disease Control and Prevention. Urinary Tract Infection 2012. http://www.cdc.gov/nhsn/forms/57.114-UTI-BLANK.pdf (accessed 25 Jul 2013).
25. Mitchell B, Ware C, McGregor A, et al. ASID (HICSIG)/AICA Position Statement: preventing catheter-associated urinary tract infections in patients. Healthcare Infect 2011;16:45-52.
26. Tenke P, Kovacs B, Bjerklund JTE, et al. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents 2008;31:68-78.
27. Mitchell B, Gardner A, Beckingham W, et al. Healthcare associated urinary tract infections: a protocol for a national point prevalence study. Healthcare Infect 2014;19:26-31.
28. Health Protection Scotland. Catheter associated urinary tract infection surveillance for acute settings. Glasgow: Health Protection Scotland, 2012.
29. Australian Institute of Health and Welfare. Australian Refined Diagnosis Related Groups (AR-DRGs). Canberra: Australian Government, 2013. http://www.aihw.gov.au/ar-drg-data-cubes/#ARDRGs (accessed 25 Jul 2013).
30. Independent Hospital Pricing Authority (IHPA). Australian Refined Diagnosis Related Groups (Version 6.0). Australian Government, 2008.
31. Zarb P, Coignard B, Griskeviciene J, et al. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill 2012;17:46.
32. Humphreys H, Newcombe RG, Enstone J, et al. Four country healthcare associated infection prevalence survey 2006: risk factor analysis. J Hosp Infect 2008;69:249-57.
33. Australian Institute of Health and Welfare. How many beds are there? Canberra: Australian Government, 2013. http://www.aihw.gov.au/haag09-10/number- of-beds/ (accessed 25 Jul 2013).
34. Collignon P, Dreimanis D, Ferguson J, et al. Bloodstream infection. In: Cruickshank M, Ferguson J. eds Reducing harm to patients from health care associated infection: the role of surveillance. Australian Commission on Safety and Quality in Health Care, 2008:53-89.
35. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309-17. (Pubitemid 39050477)
36. Platt R, Polk FB, Murdock B, et al. Mortality associated with nosocomial urinary-tract infection. N Engl J Med 1982;307:637-42. (Pubitemid 12049911)
37. Greene L, Marx J, Oriola S. An APIC guide to the elimination of catheter-associated urinary tract infections (CAUTIs): developing and applying facility-based prevention interventions in acute and long-term care settings 2008. http://www.apic.org/Resource-/EliminationGuideForm/c0790db8-2aca-4179- a7ae-676c27592de2/File/APIC-CAUTI-Guide.pdf (accessed 21 Oct 2013).
38. Mitchell BG, Gardner A, McGregor A. Healthcare-associated infections: getting the balance right in safety and quality v. public reporting. Aust Health Rev 2012;36:365-6.
39. Brown C, Richards M, Galletly T, et al. Use of anti-infective serial prevalence studies to identify and monitor hospital-acquired infection. J Hosp Infect 2009;73:34-40.
40. King C, Garcia Alvarez L, Holmes A, et al. Risk factors for healthcare-associated urinary tract infection and their applications in surveillance using hospital administrative data: a systematic review. J Hosp Infect 2012;82:219-26.
41. Centers for Medicare and Medicaid Services. Present on admission (POA) indicator reporting by acute inpatient prospective payment system (IPPS) hospitals 2012. http://www.cms.hhs.gov/HospitalAcqCond (accessed 21 Oct 2013).
42. Ong CW, Roberts JL, Collignon PJ. Long-term survival outcome following Staphylococcus aureus bacteraemia. Healthcare Infect 2013;18:102-9.
43. Saint S, Olmsted RN, Fakih MG, et al. Translating health care-associated urinary tract infection prevention research into practice via the bladder bundle. Jt Comm J Qual Patient Saf 2009;35:449-55.
44. Saint S, Meddings JA, Calfee D, et al. Catheter-associated urinary tract infection and the Medicare rule changes. Ann Intern Med 2009;150:877-84.
45. Wald HL, Kramer AM. Nonpayment for harms resulting from medical care. JAMA 2007;298:2782-4.